Syncom Formulations declares ₹0.10 per share dividend at 38th AGM
- Declared a final dividend of ₹0.10 per equity share (10% of face value) for FY26
- Adopted standalone and consolidated audited financial statements for FY26 with no qualifications
- Re-appointed Ankit Kedarmal Bankda as Whole-time Director and confirmed Rahul Vijay Bankda as MD
- Confirmed Rinki Ankit Bankda as Whole-time Director and re-appointed Ruchi Jindal as Independent Director

*this image is generated using AI for illustrative purposes only.
Syncom Formulations (India) Limited declared a final dividend of ₹0.10 per equity share for FY26 during its 38th Annual General Meeting held on September 30, 2026. The payout represents a 10% return on the face value of ₹1 per share.
The meeting, conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM), was chaired by Ankit Kedarmal Bankda. The proceedings were attended by the Board of Directors, statutory auditors from Sanjay Mehta & Associates, and secretarial auditors from D. K. Jain & Co. The quorum was met with 73 members participating through the CDSL platform, exceeding the minimum requirement of 30 members.
Key resolutions passed
Shareholders approved several ordinary and special resolutions, including the adoption of standalone and consolidated audited financial statements for the year ended March 31, 2026. The auditors' report contained no qualifications or negative remarks.
The following key appointments and confirmations were ratified:
- Re-appointment: Ankit Kedarmal Bankda as Whole-time Director.
- Confirmation: Rahul Vijay Bankda as Managing Director and Director.
- Confirmation: Rinki Ankit Bankda as Whole-time Director and Director.
- Re-appointment: Ruchi Jindal as Woman Independent Director.
- Remuneration: Approval for increased remuneration for CFO Ankur Vijay Bankda and ratification of Cost Auditor remuneration for FY27.
Governance and compliance updates
The Company Secretary informed members that remote e-voting had commenced on September 27, 2026, and concluded on September 29, 2026. Voting results will be declared within two working days of the meeting's conclusion. The company also noted that unclaimed dividends for seven consecutive years are in the process of being transferred to the Investor Education and Protection Fund (IEPF) Authority.
What the numbers show
The dividend declaration of ₹0.10 per share on 94,00,00,000 equity shares indicates a total payout obligation of approximately ₹9.4 crore. This consistent dividend policy, maintained alongside the clean audit opinion, signals financial stability to shareholders. The high shareholder engagement, with 73 attendees against a minimum of 30, reflects active investor interest despite the virtual format.
Historical Stock Returns for Syncom Formulations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.20% | +22.94% | +28.88% | +129.25% | +54.05% | +209.63% |
How will the increased remuneration for the CFO and the confirmed leadership structure impact Syncom Formulations' operational efficiency and strategic direction in FY27?
What are the implications of the clean audit opinion on the company's ability to secure favorable financing terms or attract institutional investors in the coming fiscal year?
Given the consistent dividend policy, how might Syncom Formulations balance future capital expenditure requirements with maintaining shareholder returns as it scales?


































